108
Participants
Start Date
February 15, 2015
Primary Completion Date
November 15, 2018
Study Completion Date
December 15, 2021
Niraparib
Niraparib versus Bevacizumab-Niraparib combo
Bevacizumab
Rigshospitalet, Copenhagen
Massachusetts General Hospital, Boston
Collaborators (1)
European Network of Gynaecological Oncological Trial Groups (ENGOT)
OTHER
Gynecologic Cancer Intergroup (GCIG)
OTHER
University of Utah
OTHER
Massachusetts General Hospital
OTHER
Myriad Genetics, Inc.
INDUSTRY
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
OTHER